meRfi®-GM
Exopolysaccharide (EPS) / Extracellular Polymeric Substances (EPSs)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Exopolysaccharide (EPS) / Extracellular Polymeric Substances (EPSs) and Lipopolysaccharides (LPS) have different effects. EPS does not cause inflammation when injected. This shows EPS's unique anti-inflammatory potential.
Exopolysaccharide (EPS) / Extracellular Polymeric Substances (EPSs) are high-molecular-weight polymers composed of sugar residues secreted by a microorganism into the surrounding environment
The intraperitoneal administration of Exopolysaccharide (EPS) / Extracellular Polymeric Substances (EPSs) derived from Bacillus subtilis offers protection against severe disease in mouse models of…
References (Sources)
- Exopolysaccharide production by lactic acid bacteria: the manipulation of environmental stresses for industrial applications
- Exopolysaccharides from Lactobacillus plantarum NCU116 Enhances Colonic Mucosal Homeostasis by Controlling Epithelial Cell Differentiation and c-Jun/Muc2 Signaling
- Mechanism of TLR4-Mediated Anti-Inflammatory Response Induced by Exopolysaccharide from the Probiotic Bacillus subtilis
- Potentials of Exopolysaccharides from Lactic Acid Bacteria
- Probiotic exopolysaccharide protects against systemic Staphylococcus aureus infection, inducing dual-functioning macrophages that restrict bacterial growth and limit inflammation
- Protection from intestinal inflammation by bacterial exopolysaccharides
- Suppression of Staphylococcus aureus superantigen-independent interferon gamma response by a probiotic polysaccharide